Batoclimab 340 mg SC bi-weekly clinical trials

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

This study is looking at a new medicine called batoclimab for adults with a condition called generalized Myasthenia Gravis (gMG). It wants to see how well it works and if it's safe. Participants will receive batoclimab or a dummy medicine (placebo) to see if it helps relieve their symptoms.